Novel Antibody-Drug Conjugate Demonstrates Durable Responses in Patients With Platinum-Resistant Ovarian Cancer

• by

• October 8, 2026

Beyond Detection: How AI Is Reshaping Breast Imaging and Risk-Based Screening

Artificial intelligence in breast imaging is rapidly expanding beyond computer-aided cancer detection.

• by

• October 26, 2026

• 6 min

Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

• by Stephan P. Tenbaum, Paloma Ordóñez-Morán, Isabel Puig, Irene Chicote, Oriol Arqués, Stefania Landolfi, Yolanda Fernández, José Raúl Herance, Juan D. Gispert, Leire Mendizabal, Susana Aguilar, Santiago Ramón y. Cajal, Simó Schwartz, Ana Vivancos, Eloy Espín, Santiago Rojas, José Baselga, Josep Tabernero, Alberto Muñoz, Héctor G. Palmer

• October 22, 2026

Dana-Farber Breaks Ground on Lavine Bekenstein Cancer Hospital

Historic ceremony marks the beginning of a new era in cancer care, led by Dana-Farber in collaboration with Beth Israel Deaconess Medical Center

• by

• October 19, 2026

• 4 min